New data from cohort 3 show EO2463 can be safely added to rituximab in first-line low-tumor-burden follicular lymphoma in need of treatmentAll six patients responded positively to the combination ...
And just as quickly, I think about everyone else on my list and wonder if there’s actually a gift out there that feels ...
In ongoing Phase 1 ACESOT-1051dose-escalation trial, 3 out of 4 patients at Dose Level 6 (100 mg once daily) achieved stable disease, per RECIST v1.1, in heavily pretreated gastrointestinal and ...
Children's Day 2025 drawing themes will highlight inclusive education, digital safety, mental well-being, and environmental ...
These cyberattacks cause significant data breaches in digital health information systems, which threaten patient safety and privacy. Objective: From a sociotechnical perspective, this paper explores ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback